Table 4.
Glycemic parameters, antidiabetics used, and microvascular complications of diabetes in the cases group.
| Parameter | Values |
|---|---|
| Mean duration of diabetes | 8.2 (±5.87) years |
| Antidiabetic agents used | |
| Insulin | 43 (27%) |
| Metformin | 143 (89.9%) |
| Sulphonylureas | 81 (50.9%) |
| DPP4 inhibitors | 104 (65.4%) |
| SGLT 2 inhibitors | 37 (23.2%) |
| Alpha glucosidase inhibitors | 41 (25.7%) |
| Thiazolidinediones | 0 |
| Combination (>1 agent) | 149 (93.7%) |
| Statins use | 78 (49.05%) |
| Hypertension | 81 (50.9%) |
| Dyslipidemia | 97 (61%) |
| Nephropathy | 41 (25.7%) |
| Neuropathy | 58 (36.4%) |
| Retinopathy | 33 (20.7%) |
| Fasting insulin | 13.86 (±11.25) |
| HOMA-IR | 4.87 (±4.80) |
| Urine ACR | 0.227 (±0.327) |